Latest Revenue Generation News

Avenira Limited finalised a $4.5 million strategic investment from Hebang Biotechnology and progressed key development milestones at its Wonarah Phosphate Project, signalling a focused push towards near-term production and long-term growth.

RBR Group Limited has secured $1.3 million through a capital raising initiative despite operational disruptions in Mozambique, positioning itself for growth in the LNG services sector.

Health and Plant Protein Group Limited reported a decline in cash reserves to $0.90 million for Q2 FY25, continuing its efforts to resolve a US tax withholding issue tied to a previous asset sale.

Dreadnought Resources reported a challenging quarter with significant exploration spending and a tight cash position, yet remains confident in its operational outlook and funding prospects.

Jindalee Lithium Limited reported a $935,000 net cash outflow for the December 2024 quarter, maintaining a cautious but confident stance on securing future funding to support ongoing exploration activities.

Alexium International Group reports a 16% sales increase in Q2 FY25 despite ongoing mattress market softness, driven by strategic product diversification and supply chain improvements.

Golden Horse Minerals Ltd posted a CAD 413,000 net cash outflow from operating activities in the December 2024 quarter, while maintaining a robust cash balance of CAD 13.37 million. The company’s cash burn reflects ongoing exploration and evaluation investments.

Astron Corporation Limited reported a $1.05 million net cash outflow from operations in Q4 2024 but strengthened its liquidity position with a $14.5 million inflow from financing activities, ending the quarter with $13.48 million in cash.

Gas2Grid navigates regulatory headwinds in Australia by pursuing new petroleum ventures in the Philippines while contesting a significant legal claim in France. The company’s ASX suspension persists as it seeks to restore compliance through fresh contracts.

Tigers Realm Coal is finalising the sale of its Russian subsidiaries for US$49 million, pending crucial Presidential approval, while navigating recent leadership shifts.

Mt Malcolm Mines NL reports a successful quarter with 122.4 ounces of gold doré produced from its Golden Crown Prospect, generating AUD$449,194 in revenue and confirming high-grade mineralisation.

Zelira Therapeutics has secured a fourth funding tranche of US$681,000, advancing its HOPE® Autism Spectrum Disorder FDA trial process and bringing total funding to US$3.25 million. The company is progressing clinical validation and product development, including the transformation of Zenivol® into a capsule formulation.